Aurobindo Pharma Executive and Leadership Team

Kuoni Singh, the EA and Admin To Chief Executive Officer at Aurobindo Pharma, manages complex executive workflows and administrative priorities. By coordinating high-level communications between the Chief Executive Officer and internal departments, Singh ensures seamless operational continuity. The EA and Admin To Chief Executive Officer facilitates critical decision-making processes by organizing board materials and tracking strategic milestones. Kuoni Singh maintains rigorous oversight of scheduling and resource allocation to support the company's global pharmaceutical manufacturing goals. This role requires constant interaction with senior leadership to align administrative support with the broader corporate mission. By streamlining daily operations, Singh enables the executive team to focus on long-term growth and market expansion. The EA and Admin To Chief Executive Officer provides essential support for the firm's international presence, ensuring that administrative functions remain robust and efficient across all regional operations.

Satakarni Makkapati, the Chief Executive Officer - Biologics, Vaccines and Peptides at Aurobindo Pharma, directs the research, development, and commercialization of advanced therapeutic products. Overseeing the expansion of the biologics portfolio, Makkapati ensures that the company meets stringent global regulatory standards for vaccines and peptides. The Chief Executive Officer - Biologics, Vaccines and Peptides collaborates with R&D teams to accelerate the pipeline of complex generic drugs. Satakarni Makkapati drives innovation in manufacturing processes to maintain a competitive edge in the global pharmaceutical market. This leadership role involves managing large-scale clinical development programs and securing market access for new therapeutic offerings. By optimizing the development lifecycle, Makkapati enhances the company's ability to address critical health needs. The Chief Executive Officer - Biologics, Vaccines and Peptides maintains a focus on scaling production capabilities to support international demand for high-value pharmaceutical ingredients.

Santhanam Subramanian, the Chief Financial Officer at Aurobindo Pharma, manages the global financial strategy, capital allocation, and fiscal reporting for the organization. Overseeing the company's financial health, Subramanian ensures that investments in pharmaceutical manufacturing and R&D align with long-term growth objectives. The Chief Financial Officer monitors market trends and currency fluctuations to mitigate risks associated with international trade. Santhanam Subramanian coordinates with the Board of Directors to maintain transparency and drive shareholder value through disciplined cost management. This leadership role involves optimizing the balance sheet to support the expansion of the company's diverse therapeutic portfolio. By implementing robust financial controls, the Chief Financial Officer secures the resources necessary for sustained innovation. Subramanian directs the financial planning and analysis teams to provide actionable insights that guide strategic decision-making across all global business units and manufacturing facilities.

Anil Jain, the Chief Operating Officer API Division at Aurobindo Pharma, oversees the large-scale production and supply chain logistics for active pharmaceutical ingredients. Managing complex manufacturing operations, Jain ensures that the company maintains high quality standards while meeting global demand for essential chemical components. The Chief Operating Officer API Division drives efficiency improvements across all production sites to reduce costs and increase output. Anil Jain coordinates with procurement and quality assurance teams to guarantee the integrity of the supply chain. This leadership role involves scaling manufacturing capacity to support the company's broad portfolio of antibiotics and other therapeutic areas. By optimizing operational workflows, the Chief Operating Officer API Division enhances the firm's ability to deliver consistent, high-quality ingredients to international markets. Jain maintains a focus on operational excellence to support the company's position as a leading global manufacturer.

Vijay Kondakkagari, the Manager, Information Technology at Aurobindo Pharma, directs the digital infrastructure and cybersecurity initiatives that support global pharmaceutical operations. Overseeing the integration of advanced data systems, Kondakkagari ensures that manufacturing and research teams have secure, reliable access to critical information. The Manager, Information Technology implements scalable software solutions to streamline internal processes and enhance data analytics capabilities. Vijay Kondakkagari collaborates with department heads to align technology investments with the company's strategic goals for digital transformation. This leadership role involves managing the IT budget and overseeing the deployment of enterprise-wide systems that support global regulatory compliance. By maintaining a robust technological framework, the Manager, Information Technology protects the company's intellectual property and operational data. Kondakkagari drives the adoption of modern digital tools to improve productivity and support the company's mission of delivering high-quality pharmaceuticals to international markets.